LA
Therapeutic Areas
Osel Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MO-03 (CBM588) | Advanced/Metastatic Renal Cell Carcinoma (in combo with IO) | Phase 3 |
| LACTIN-V | Recurrent Bacterial Vaginosis | Phase 2 |
| MucoCept-HIV | HIV Prevention in Women | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| MO-03 (CBM588) | Advanced/Metastatic Renal Cell Carcinoma (in combo with IO) | Phase 3 |
| LACTIN-V | Recurrent Bacterial Vaginosis | Phase 2 |
| MucoCept-HIV | HIV Prevention in Women | Preclinical |